PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
3.85
Current ratio of 3.85 while RVPH has zero ratio. Bruce Berkowitz would examine if our liquidity management provides advantages.
3.85
Quick ratio of 3.85 while RVPH has zero ratio. Bruce Berkowitz would examine if our liquidity management provides advantages.
3.77
Cash ratio of 3.77 while RVPH has zero cash ratio. Bruce Berkowitz would examine if our cash management provides competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-53.22
Negative short-term coverage while RVPH shows 0.00. Joel Greenblatt would look for cash flow improvements and refinancing catalysts.